The state’s abortion bans make no exceptions for fatal fetal anomalies. Two women had devastating pregnancy diagnoses — one could leave the state for an abortion, and the other could not.
Category: NPR
Abortion access could continue to change in year 2 after the overturn of Roe v. Wade
It’s already harder to get an abortion in many places and access is likely to be limited more with the passage of new laws.
How medical schools are faring with training students to care for the LGBTQ community
NPR’s Miles Parks speaks to psychiatrist Alex Keuroghlian about the state of training for medical students to care for the LGBTQ community.
Opioids are not the best way to treat short-term back pain, study finds
A carefully conducted study of treatments for short-term back pain finds that opioids aren’t the best approach. The results throw into question current guidelines.
In Texas, a rare program offers hope for some of the most vulnerable women and babies
Many pregnant people struggling with substance abuse don’t want to get help for fear of losing their children to the state. Casa Mía offers safe harbor.
Malaria cases in Texas and Florida are the first U.S. spread since 2003, the CDC says
Four of the cases were found in Florida, while the fifth was logged in Texas, according to the Centers for Disease Control and Prevention.
An Alzheimer’s drug could soon be approved, but accessing it may still be difficult
The Food and Drug Administration may soon grant full approval to an Alzheimer’s drug. When it does, Medicare will start more widely covering the costly drug — but hurdles to access remain.
Intermittent fasting is as effective as counting calories, new study finds
Limiting when you eat to a 6- or 8-hour window can help reduce calorie intake. While the weight loss isn’t dramatic, it may be easier to stick to than counting calories.
How careers in public service taught one couple to fight to cure ALS
NPR’s Juana Summers tracks the advocacy efforts of husband and wife Brian Wallach and Sandra Abrevaya as they try and change the landscape for ALS patients.
An Alzheimer’s drug is on the way, but getting it may still be tough. Here’s why
The Food and Drug Administration is expected to grant full approval to the Alzheimer’s drug lecanemab by July 6. But access to the drug may still be limited.
